Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
HOOKIPA Pharma Inc. - Common Stock
(NQ:
HOOK
)
1.550
+0.020 (+1.31%)
Streaming Delayed Price
Updated: 12:12 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HOOKIPA Pharma Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 21, 2023
It's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning!
Via
InvestorPlace
HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences
December 21, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
November 20, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Earnings Preview For HOOKIPA Pharma
November 08, 2023
Via
Benzinga
Analyst Ratings for HOOKIPA Pharma
September 27, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About HOOKIPA Pharma
June 05, 2023
Via
Benzinga
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
November 03, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
November 02, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Recap: HOOKIPA Pharma Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Outlook For HOOKIPA Pharma
May 10, 2023
Via
Benzinga
HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab as First-Line Treatment in Patients with HPV16+ Head and Neck Cancers at European Society for Medical Oncology Congress 2023
October 22, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 19, 2023
Via
Benzinga
HOOKIPA Pharma announces publication of preclinical data of hepatitis B virus (HBV) therapeutic vaccine developed in collaboration with Gilead Sciences
October 18, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Announces Executive Leadership Change
September 13, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
7 Biotech Stocks to Sell in September Before They Crash & Burn
September 06, 2023
These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues.
Via
InvestorPlace
HOOKIPA Pharma to participate in upcoming investor conferences in September
September 06, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 10, 2023
August 03, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying
July 12, 2023
The Dow Jones closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
TeraWulf And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
July 10, 2023
The Dow Jones closed lower by over 180 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
CURO Group And 2 Other Stocks Under $3 Insiders Are Aggressively Buying
July 06, 2023
The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
HOOKIPA Pharma And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
July 05, 2023
The Dow Jones closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 13, 2023
Via
Benzinga
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
June 10, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
HOOKIPA Pharma Announces Pricing of $50.0 Million Public Offering of Common Stock and Non-Voting Convertible Preferred Stock
May 31, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data on HB-200 in Combination with Pembrolizumab in Patients with HPV16+ Head and Neck Cancers
May 31, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 11, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.